Evidence generation plan for digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments

4 Monitoring

Companies must respond to NICE confirming:

  • within 6 months of publication of this plan, that agreements are in place to generate the evidence

  • annually, that the data is being collected and analysed as planned.

The companies should tell NICE as soon as possible of anything that may affect ongoing evidence generation, including:

  • any substantial risk that the evidence will not be collected as planned

  • new safety concerns

  • the technology significantly changing in a way that affects the evidence generation process.

If data collection is expected to end later than planned, the companies should contact NICE to arrange an extension to the evidence generation period. NICE reserves the right to withdraw the guidance if data collection is delayed, or if it is unlikely to resolve the evidence gaps.

This page was last updated: